Ketress Tablet 40mg




Ketress Tablet 40mg Indications

Ketress 40mg Tablet is primarily indicated in conditions like Colon tumor, Colorectal cancer, Hook worm infection, Malignant neoplasms, Roundworm infection, and can also be given in adjunctive therapy as an alternative drug of choice in Ascariasis, Head and neck cancer.


Ketress 40mg Tablet is contraindicated in conditions like Hepatic disease, Hypersensitivity,Psoriatic arthropathy, Blood disorders.

Side Effects

The severe or irreversible adverse effects of Ketress 40mg Tablet, which give rise to further complications include Thrombocytopenia, Allergic reactions, Confusion, Granulocytopenia, Seizures, Numbness, Fatigue.Ketress 40mg Tablet produces potentially life-threatening effects which include Agranulocytosis, Attended secondary infections, Attended secondary infections. which are responsible for the discontinuation of Ketress 40mg Tablet therapy. The signs and symptoms that are produced after the acute overdosage of Ketress 40mg Tablet include Nausea, Vomiting, Diarrhea, Confusion, Abdominal cramps, Lethargy.The symptomatic adverse reactions produced by Ketress 40mg Tablet are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Nausea, Vomiting, Diarrhea, Fever, Abdominal pain, Rashes, Pruritus, Itching, Taste disturbance, Arthralgia, Giddiness, Cutaneous vasculitis, Soreness, Flu like syndrome, Smell disturbances, dizziness.


Avoid use of alcohol and alcohol containing products while taking Ketress 40mg Tablet. Severe stomach upset, flushing and headache can occur. It is not recommended for use in pregnant or nursing women or in children. Avoid contact with people having cold, flu etc as its use may decrease immunity. Avoid contact with those who had recently been vaccinated with a live vaccine. Alcohol should be avoided. It should be avoided in pateints with prexisting blood disorder.


There are no reviews yet.

Be the first to review “Ketress Tablet 40mg”

Your email address will not be published.